Correlation of mean apparent diffusion coefficient (ADC) and maximal standard uptake value (SUVmax) evaluated by diffusion-weighted MRI and 18F-FDG-PET/CT in children with Hodgkin lymphoma: a feasibility study

1. The Lancet Haematology. New guidelines for paediatric Hodgkin lymphoma. Lancet Haematol 2020; 7: e851. doi: 10.1016/S2352-3026(20)30371-9 The Lancet Haematology New guidelines for paediatric Hodgkin lymphoma Lancet Haematol 2020 7 e851 10.1016/S2352-3026(20)30371-9 Open DOISearch in Google Scholar

2. Nagpal P, Akl MR, Ayoub NM, Tomiyama T, Cousins T, Tai B, et al. Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine. Oncotarget 2016; 7: 67551–73. doi: 10.18632/onco-target.11509 NagpalP AklMR AyoubNM TomiyamaT CousinsT TaiB Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine Oncotarget 2016 7 67551 73 10.18632/onco-target.11509 Open DOISearch in Google Scholar

3. Ansell SM. Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc 2015; 90: 1574–83. doi: 10.1016/j.mayocp.2015.07.005 AnsellSM Hodgkin lymphoma: diagnosis and treatment Mayo Clin Proc 2015 90 1574 83 10.1016/j.mayocp.2015.07.005 Open DOISearch in Google Scholar

4. Ehrhardt MJ, Flerlage JE, Armenian SH, Castellino SM, Hodgson DC, Hudson MM. Integration of pediatric Hodgkin lymphoma treatment and late effects guidelines: seeing the forest beyond the trees. J Natl Compr Canc Netw 2021; 19: 755–64. doi: 10.6004/jnccn.2021.7042 EhrhardtMJ FlerlageJE ArmenianSH CastellinoSM HodgsonDC HudsonMM Integration of pediatric Hodgkin lymphoma treatment and late effects guidelines: seeing the forest beyond the trees J Natl Compr Canc Netw 2021 19 755 64 10.6004/jnccn.2021.7042 Open DOISearch in Google Scholar

5. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, et al. Hodgkin lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2020; 18: p. 755–81. doi: 10.6004/jnccn.2020.0026 HoppeRT AdvaniRH AiWZ AmbinderRF ArmandP BelloCM Hodgkin lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology J Natl Compr Canc Netw 2020 18 755 81 10.6004/jnccn.2020.0026 Open DOISearch in Google Scholar

6. Kluge R, Kurch L, Georgi T, Metzger M. Current role of FDG-PET in pediatric Hodgkin's lymphoma. Semin Nucl Med 2017; 47: 242–57. doi: 10.1053/j.semnuclmed.2017.01.001 KlugeR KurchL GeorgiT MetzgerM Current role of FDG-PET in pediatric Hodgkin's lymphoma Semin Nucl Med 2017 47 242 57 10.1053/j.semnuclmed.2017.01.001 Open DOISearch in Google Scholar

7. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014; 32: 3059–68. doi: 10.1200/JCO.2013.54.8800 ChesonBD FisherRI BarringtonSF CavalliF SchwartzLH ZuccaE Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification J Clin Oncol 2014 32 3059 68 10.1200/JCO.2013.54.8800 Open DOISearch in Google Scholar

8. Zaucha JM, Chauvie S, Zaucha R, Biggii A, Gallamini A. The role of PET/CT in the modern treatment of Hodgkin lymphoma. Cancer Treat Rev 2019; 77: 44–56. doi: 10.1016/j.ctrv.2019.06.002 ZauchaJM ChauvieS ZauchaR BiggiiA GallaminiA The role of PET/CT in the modern treatment of Hodgkin lymphoma Cancer Treat Rev 2019 77 44 56 10.1016/j.ctrv.2019.06.002 Open DOISearch in Google Scholar

9. El-Galaly TC, Villa D, Gormsen LC, Baech J, Lo A, Cheah CY. FDG-PET/CT in the management of lymphomas: current status and future directions. J Intern Med 2018; 284: 358–76. doi: 10.1111/joim.12813 El-GalalyTC VillaD GormsenLC BaechJ LoA CheahCY FDG-PET/CT in the management of lymphomas: current status and future directions J Intern Med 2018 284 358 76 10.1111/joim.12813 Open DOISearch in Google Scholar

10. Kertész H, Beyer T, London K, Saleh H, Chung D, Rausch I, et al. Reducing radiation exposure to paediatric patients undergoing [18F]FDG-PET/CT imaging. Mol Imaging Biol 2021; 23: 775–86. doi: 10.1007/s11307-021-01601-4 KertészH BeyerT LondonK SalehH ChungD RauschI Reducing radiation exposure to paediatric patients undergoing [18F]FDG-PET/CT imaging Mol Imaging Biol 2021 23 775 86 10.1007/s11307-021-01601-4 Open DOISearch in Google Scholar

11. Banka P, Geva T. Advances in pediatric cardiac MRI. Curr Opin Pediatr 2016; 28: 575–83. doi: 10.1097/MOP.0000000000000400 BankaP GevaT Advances in pediatric cardiac MRI Curr Opin Pediatr 2016 28 575 83 10.1097/MOP.0000000000000400 Open DOISearch in Google Scholar

12. Daneman A. Special issue: Pediatric imaging. Acta Radiol 2013; 54: 982. doi: 10.1258/ar.2012.12a008 DanemanA Special issue: Pediatric imaging Acta Radiol 2013 54 982 10.1258/ar.2012.12a008 Open DOISearch in Google Scholar

13. Davis JT, Kwatra N, Schooler GR. Pediatric whole-body MRI: a review of current imaging techniques and clinical applications. J Magn Reson Imaging 2016; 44: 783–93. doi: 10.1002/jmri.25259 DavisJT KwatraN SchoolerGR Pediatric whole-body MRI: a review of current imaging techniques and clinical applications J Magn Reson Imaging 2016 44 783 93 10.1002/jmri.25259 Open DOISearch in Google Scholar

14. Shapira-Zaltsberg G, Wilson N, Trejo Perez E, Abbott L, Dinning S, Kapoor C, et al. Whole-body diffusion-weighted MRI compared to (18 F)FDG PET/CT in initial staging and therapy response assessment of Hodgkin lymphoma in pediatric patients. Can Assoc Radiol J 2020; 71: 217–25. doi: 10.1177/0846537119888380 Shapira-ZaltsbergG WilsonN Trejo PerezE AbbottL DinningS KapoorC Whole-body diffusion-weighted MRI compared to (18 F)FDG PET/CT in initial staging and therapy response assessment of Hodgkin lymphoma in pediatric patients Can Assoc Radiol J 2020 71 217 25 10.1177/0846537119888380 Open DOISearch in Google Scholar

15. Bozdağ M, Er A, Çinkooğlu A. Histogram Analysis of ADC Maps for differentiating brain metastases from different histological types of lung cancers. Can Assoc Radiol J 2021; 72: 271–8. doi: 10.1177/0846537120933837 BozdağM ErA ÇinkooğluA Histogram Analysis of ADC Maps for differentiating brain metastases from different histological types of lung cancers Can Assoc Radiol J 2021 72 271 8 10.1177/0846537120933837 Open DOISearch in Google Scholar

16. Juan CJ, Lin SC, Li YH, Chang CC, Jeng YH, Peng HH, et al. Improving interobserver agreement and performance of deep learning models for segmenting acute ischemic stroke by combining DWI with optimized ADC thresholds. Eur Radiol 2022; 32: 5371–81. doi: 10.1007/s00330-022-08633-6 JuanCJ LinSC LiYH ChangCC JengYH PengHH Improving interobserver agreement and performance of deep learning models for segmenting acute ischemic stroke by combining DWI with optimized ADC thresholds Eur Radiol 2022 32 5371 81 10.1007/s00330-022-08633-6 Open DOISearch in Google Scholar

17. Lee SM, Lee KW, Kim MA, Song YS, Goo JM, Park CM. Serial texture analyses on ADC maps for evaluation of antiangiogenic therapy in rat breast cancer. Anticancer Res 2019; 39: 1875–82. doi: 10.21873/anticanres.13295 LeeSM LeeKW KimMA SongYS GooJM ParkCM Serial texture analyses on ADC maps for evaluation of antiangiogenic therapy in rat breast cancer Anticancer Res 2019 39 1875 82 10.21873/anticanres.13295 Open DOISearch in Google Scholar

18. Manetta R, Palumbo P, Gianneramo C, Bruno F, Arrigoni F, Natella R, et al. Correlation between ADC values and Gleason score in evaluation of prostate cancer: multicentre experience and review of the literature. Gland Surg 2019; 8(Suppl 3): S216–22. doi: 10.21037/gs.2019.05.02 ManettaR PalumboP GianneramoC BrunoF ArrigoniF NatellaR Correlation between ADC values and Gleason score in evaluation of prostate cancer: multicentre experience and review of the literature Gland Surg 2019 8 Suppl 3 S216 22 10.21037/gs.2019.05.02 Open DOISearch in Google Scholar

19. Schober P, Boer C, Schwarte LA. Correlation Coefficients: appropriate use and interpretation. Anesth Analg 2018; 126: 1763–8. doi: 10.1213/ANE.0000000000002864 SchoberP BoerC SchwarteLA Correlation Coefficients: appropriate use and interpretation Anesth Analg 2018 126 1763 8 10.1213/ANE.0000000000002864 Open DOISearch in Google Scholar

20. Schober P, Mascha EJ, Vetter TR. Statistics from A (Agreement) to Z (z Score): a guide to interpreting common measures of association, agreement, diagnostic accuracy, effect size, heterogeneity, and reliability in medical research. Anesth Analg 2021; 133: 1633–41. doi: 10.1213/ANE.0000000000005773 SchoberP MaschaEJ VetterTR Statistics from A (Agreement) to Z (z Score): a guide to interpreting common measures of association, agreement, diagnostic accuracy, effect size, heterogeneity, and reliability in medical research Anesth Analg 2021 133 1633 41 10.1213/ANE.0000000000005773 Open DOISearch in Google Scholar

21. Landis JR, Koch GG. Koch, The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–74. PMID: 843571 LandisJR KochGG Koch, The measurement of observer agreement for categorical data Biometrics 1977 33 159 74 PMID: 843571 Search in Google Scholar

22. Kamal NM, Elsaban K. Role of 18f-fdg-pet/ct in assessment of pediatric Hodgkin's lymphoma. Q J Nucl Med Mol Imaging 2021; 65: 376–85. doi: 10.23736/S1824-4785.16.02695-9 KamalNM ElsabanK Role of 18f-fdg-pet/ct in assessment of pediatric Hodgkin's lymphoma Q J Nucl Med Mol Imaging 2021 65 376 85 10.23736/S1824-4785.16.02695-9 Open DOISearch in Google Scholar

23. Qiu L, Chen Y, Wu J. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma. Hell J Nucl Med 2013; 16: 230–6. doi: 10.1967/s0024499100091 QiuL ChenY WuJ The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma Hell J Nucl Med 2013 16 230 6 10.1967/s0024499100091 Open DOISearch in Google Scholar

24. Verhagen MV, Menezes LJ, Neriman D, Watson TA, Punwani S, Taylor SA, et al. (18)F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with (18) F-FDG PET/CT as the reference standard. J Nucl Med 2021; 62: 1524–30. doi: 10.2967/jnumed.120.260059 VerhagenMV MenezesLJ NerimanD WatsonTA PunwaniS TaylorSA (18)F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with (18) F-FDG PET/CT as the reference standard J Nucl Med 2021 62 1524 30 10.2967/jnumed.120.260059 Open DOISearch in Google Scholar

25. Chu C, Gao Y, Lan X, Lin J, Thomas AM, Li S. Stem-cell therapy as a potential strategy for radiation-induced brain injury. Stem Cell Rev Rep 2020; 16: 639–49. doi: 10.1007/s12015-020-09984-7 ChuC GaoY LanX LinJ ThomasAM LiS Stem-cell therapy as a potential strategy for radiation-induced brain injury Stem Cell Rev Rep 2020 16 639 49 10.1007/s12015-020-09984-7 Open DOISearch in Google Scholar

26. Linet MS, Slovis TL, Miller DL, Kleinerman R, Lee C, Rajaraman P, et al. Cancer risks associated with external radiation from diagnostic imaging procedures. CA Cancer J Clin 2012; 62: 75–100. doi: 10.3322/caac.21132 LinetMS SlovisTL MillerDL KleinermanR LeeC RajaramanP Cancer risks associated with external radiation from diagnostic imaging procedures CA Cancer J Clin 2012 62 75 100 10.3322/caac.21132 Open DOISearch in Google Scholar

27. Kollmann C, Jenderka KV, Moran CM, Draghi F, Jimenez Diaz JF, Sande R. EFSUMB clinical safety statement for diagnostic ultrasound - (2019 revision). Ultraschall Med 2020; 41: 387–9. doi: 10.1055/a-1010-6018 KollmannC JenderkaKV MoranCM DraghiF Jimenez DiazJF SandeR EFSUMB clinical safety statement for diagnostic ultrasound - (2019 revision) Ultraschall Med 2020 41 387 9 10.1055/a-1010-6018 Open DOISearch in Google Scholar

28. Albano D, Bruno A, Patti C, Micci G, Midiri M, Tarella C, et al. Whole-body magnetic resonance imaging (WB-MRI) in lymphoma: state of the art. Hematol Oncol 2020; 38: 12–21. doi: 10.1002/hon.2676 AlbanoD BrunoA PattiC MicciG MidiriM TarellaC Whole-body magnetic resonance imaging (WB-MRI) in lymphoma: state of the art Hematol Oncol 2020 38 12 21 10.1002/hon.2676 Open DOISearch in Google Scholar

29. Galia M, Albano D, Tarella C, Patti C, Sconfienza LM, Mulè A, et al. Whole-body magnetic resonance in indolent lymphomas under watchful waiting: the time is now. Eur Radiol 2018; 28: 1187–93. doi: 10.1007/s00330-017-5071-x GaliaM AlbanoD TarellaC PattiC SconfienzaLM MulèA Whole-body magnetic resonance in indolent lymphomas under watchful waiting: the time is now Eur Radiol 2018 28 1187 93 10.1007/s00330-017-5071-x Open DOISearch in Google Scholar

30. Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, et al. Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study. Eur Radiol 2021; 31: 1494–504. doi: 10.1007/s00330-020-07182-0 SpijkersS LittooijAS KweeTC TolboomN BeishuizenA BruinMCA Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study Eur Radiol 2021 31 1494 504 10.1007/s00330-020-07182-0 Open DOISearch in Google Scholar

31. Kıvrak AS, Paksoy Y, Erol C, Koplay M, Özbek S, Kara F. Comparison of apparent diffusion coefficient values among different MRI platforms: a multi-center phantom study. Diagn Interv Radiol 2013; 19: 433–7. doi: 10.5152/dir.2013.13034 KıvrakAS PaksoyY ErolC KoplayM ÖzbekS KaraF Comparison of apparent diffusion coefficient values among different MRI platforms: a multi-center phantom study Diagn Interv Radiol 2013 19 433 7 10.5152/dir.2013.13034 Open DOISearch in Google Scholar

32. Hoang-Dinh A, Nguyen-Quang T, Bui-Van L, Gonindard-Melodelima C, Souchon R, Rouvière O. Reproducibility of apparent diffusion coefficient measurement in normal prostate peripheral zone at 1.5T MRI. Diagn Interv Imaging 2022; 103: 545–54. doi: 10.1016/j.diii.2022.06.001 Hoang-DinhA Nguyen-QuangT Bui-VanL Gonindard-MelodelimaC SouchonR RouvièreO Reproducibility of apparent diffusion coefficient measurement in normal prostate peripheral zone at 1.5T MRI Diagn Interv Imaging 2022 103 545 54 10.1016/j.diii.2022.06.001 Open DOISearch in Google Scholar

33. Newitt DC, Zhang Z, Gibbs JE, Partridge SC, Chenevert TL, Rosen MA, et al. Test-retest repeatability and reproducibility of ADC measures by breast DWI: results from the ACRIN 6698 trial. J Magn Reson Imaging 2019; 49: 1617–28. doi: 10.1002/jmri.26539 NewittDC ZhangZ GibbsJE PartridgeSC ChenevertTL RosenMA Test-retest repeatability and reproducibility of ADC measures by breast DWI: results from the ACRIN 6698 trial J Magn Reson Imaging 2019 49 1617 28 10.1002/jmri.26539 Open DOISearch in Google Scholar

34. Sadinski M, Medved M, Karademir I, Wang S, Peng Y, Jiang, et al. Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate. Abdom Imaging 2015; 40: 2523–8. doi: 10.1007/s00261-015-0396-x SadinskiM MedvedM KarademirI WangS PengY Jiang Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate Abdom Imaging 2015 40 2523 8 10.1007/s00261-015-0396-x Open DOISearch in Google Scholar